Ascendis Pharma has teamed up with an investor syndicate that includes Frazier Life Sciences, RA Capital Management, venBio and HealthQuest Capital to launch ophthalmology company Eyconis.
New ophthalmology company hits the market
Ascendis Pharma has teamed up with an investor syndicate that includes Frazier Life Sciences, RA Capital Management, venBio and HealthQuest Capital to launch ophthalmology company Eyconis.